Longevity and Mechanism of Heterosubtypic Protection Induced by M2SR (M2-Deficient Single-Replication) Live Influenza Virus Vaccine in Mice

被引:3
|
作者
Sarawar, Sally [1 ]
Gabaglia, Claudia R. [1 ]
Sanchez, Adriana [1 ]
Hatta, Yasuko [2 ]
Dias, Peter [1 ]
Neumann, Gabriele [3 ]
Kawaoka, Yoshihiro [3 ,4 ,5 ]
Bilsel, Pamuk [2 ]
机构
[1] Biomed Res Inst Southern Calif, Oceanside, CA 92056 USA
[2] FluGen Inc, Madison, WI 53711 USA
[3] Univ Wisconsin, Influenza Res Inst, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53711 USA
[4] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Microbiol & Immunol,Div Virol, Tokyo 1088639, Japan
[5] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens, Tokyo 1088639, Japan
基金
美国国家卫生研究院;
关键词
influenza; vaccine; duration; antibody; heterosubtypic; depletion; A VIRUS; IMMUNITY; INFECTION; ANTIBODIES; PROTEIN; CELLS;
D O I
10.3390/vaccines10122131
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Seasonal influenza and the threat of global pandemics present a continuing threat to public health. However, conventional inactivated influenza vaccines (IAVs) provide little cross-protective immunity and suboptimal efficacy, even against well-matched strains. Furthermore, the protection against matched strains has been shown to be of a short duration in both mouse models and humans. M2SR (M2-deficient single-replication influenza virus) is a single-replication vaccine that has been shown to provide effective cross-protection against heterosubtypic influenza viruses in both mouse and ferret models. In the present study, we investigated the duration and mechanism of heterosubtypic protection induced by M2SR in a mouse model. We previously showed that M2SR generated from influenza A/Puerto Rico/8/34 (H1N1) significantly protected C57BL/6 mice against lethal challenge with both influenza A/Puerto Rico/8/34 (H1N1, homosubtypic) and influenza A/Aichi/2/1968 (H3N2, heterosubtypic), whereas the inactivated influenza vaccine provided no heterosubtypic protection. The homosubtypic protection induced by M2SR was robust and lasted for greater than 1 year, whereas that provided by the inactivated vaccine lasted for less than 6 months. The heterosubtypic protection induced by M2SR was of a somewhat shorter duration than the homosubtypic protection, with protection being evident 9 months after vaccination. However, heterosubtypic protection was not observed at 14 months post vaccination. M2SR has been shown to induce strong systemic and mucosal antibody and T cell responses. We investigated the relative importance of these immune mechanisms in heterosubtypic protection, using mice that were deficient in B cells or mice that were depleted of T cells immediately before challenge. Somewhat surprisingly, the heterosubtypic protection was completely dependent on B cells in this model, whereas the depletion of T cells had no significant effect on survival after a lethal heterosubtypic challenge. While antibody-dependent cellular cytotoxicity (ADCC) has been demonstrated to be important in the response to some influenza vaccines, a lack of Fc receptors did not affect the survival of M2SR-vaccinated mice following a lethal challenge. We examined the influenza proteins targeted by the heterosubtypic antibody response. Shortly after the H1N1 M2SR vaccination, high titers of cross-reactive antibodies to heterosubtypic H3N2 nucleoprotein (NP) and lower titers to the stalk region of the hemagglutinin (HA2) and neuraminidase (NA) proteins were observed. The high antibody titers to heterosubtypic NP persisted one year after vaccination, whereas the antibody titers to the heterosubtypic HA2 and NA proteins were very low, or below the limit of detection, at this time. These results show that the intranasal M2SR vaccine elicits durable protective immune responses against homotypic and heterosubtypic influenza infection not seen with intramuscular inactivated vaccines. Both the homo- and heterosubtypic protection induced by the single-replication vaccine are dependent on B cells in this model. While the homosubtypic protection is mediated by antibodies to the head region of HA, our data suggest that the heterosubtypic protection for M2SR is due to cross-reactive antibodies elicited against the NP, HA2, and NA antigens that are not targeted by current seasonal influenza vaccines.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats
    Wenling Wang
    Baoying Huang
    Xiuping Wang
    Wenjie Tan
    Li Ruan
    Virologica Sinica, 2019, 34 (05) : 583 - 591
  • [42] Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats
    Wenling Wang
    Baoying Huang
    Xiuping Wang
    Wenjie Tan
    Li Ruan
    Virologica Sinica, 2019, (05) : 583 - 591
  • [43] Replication-defective virus vaccine-induced protection of mice from genital herpes simplex virus 2 requires CD4 T cells
    Morrison, Lynda A.
    VIROLOGY, 2008, 376 (01) : 205 - 210
  • [44] Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin
    Bo Ryoung Park
    Ki-Hye Kim
    Tatiana Kotomina
    Min-Chul Kim
    Young-Man Kwon
    Subbiah Jeeva
    Yu-Jin Jung
    Noopur Bhatnagar
    Irina Isakova-Sivak
    Daria Mezhenskaya
    Larisa Rudenko
    Bao-Zhong Wang
    Sang-Moo Kang
    Scientific Reports, 11
  • [45] Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin
    Park, Bo Ryoung
    Kim, Ki-Hye
    Kotomina, Tatiana
    Kim, Min-Chul
    Kwon, Young-Man
    Jeeva, Subbiah
    Jung, Yu-Jin
    Bhatnagar, Noopur
    Isakova-Sivak, Irina
    Mezhenskaya, Daria
    Rudenko, Larisa
    Wang, Bao-Zhong
    Kang, Sang-Moo
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [46] Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells
    Cox, Freek
    Baart, Matthijs
    Huizingh, Jeroen
    Tolboom, Jeroen
    Dekking, Liesbeth
    Goudsmit, Jaap
    Saeland, Eirikur
    Radosevic, Katarina
    PLOS ONE, 2015, 10 (12):
  • [47] Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses
    Lee, Young-Tae
    Ko, Eun-Ju
    Lee, Youri
    Kim, Ki-Hye
    Kim, Min-Chul
    Lee, Yu-Na
    Kang, Sang-Moo
    PLOS ONE, 2018, 13 (01):
  • [48] HA and M2 sequences alter the replication of 2013-16 H1 live attenuated influenza vaccine infection in human nasal epithelial cell cultures
    Canaday, Laura M.
    Resnick, Jessica D.
    Liu, Hsuan
    Powell, Harrison
    McCoy, Alyssa M.
    Nguyen, Dat
    Pekosz, Andrew
    VACCINE, 2022, 40 (32) : 4544 - 4553
  • [49] Immune responses of mice inoculated with recombinant Lactobacillus plantarum NC8 expressing the fusion gene HA2 and 3M2e of the influenza virus and protection against different subtypes of influenza virus
    Feng, Bo
    Yang, Wen-Tao
    Shonyela, Seria Masole
    Jin, Yu-Bei
    Huang, Ke-Yan
    Shao, Li-Na
    Wang, Cong
    Zhou, You
    Li, Qiong-Yan
    Jiang, Yan-Long
    Huang, Hai-Bin
    Shi, Chun-Wei
    Wang, Jian-Zhong
    Wang, Guan
    Kang, Yuan-Huan
    Yang, Gui-Lian
    Wang, Chun-Feng
    VIRUS RESEARCH, 2019, 263 : 64 - 72
  • [50] Co-Delivery of M2e Virus-Like Particles with Influenza Split Vaccine to the Skin Using Microneedles Enhances the Efficacy of Cross Protection
    Kim, Min-Chul
    Kim, Ki-Hye
    Lee, Jeong Woo
    Lee, Yu-Na
    Choi, Hyo-Jick
    Jung, Yu-Jin
    Kim, Yu-Jin
    Compans, Richard W.
    Prausnitz, Mark R.
    Kang, Sang-Moo
    PHARMACEUTICS, 2019, 11 (04):